We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
326
Acadia Pharmaceuticals
ACAD
$4.25B
$3.54M 0.07%
127,000
+66,000
+108% +$1.97M
ZGNX
327
DELISTED
Zogenix, Inc.
ZGNX
$3.52M 0.07%
243,000
RCI icon
328
Rogers Communications
RCI
$17.7B
$3.52M 0.07%
74,649
+54,148
+264% +$2.5M
SLAB icon
329
Silicon Laboratories
SLAB
$7.15B
$3.52M 0.07%
51,438
+2,787
+6% +$201K
PEG icon
330
Public Service Enterprise Group
PEG
$39.8B
$3.51M 0.07%
81,614
+47,872
+142% +$2.12M
TTWO icon
331
Take-Two Interactive
TTWO
$43B
$3.5M 0.07%
+47,761
New +$3.27M
ODP
332
DELISTED
ODP
ODP
$3.49M 0.07%
61,872
+17,988
+41% +$925K
MDCO
333
DELISTED
Medicines Co
MDCO
$3.42M 0.06%
90,000
+13,000
+17% +$579K
CSX icon
334
CSX Corp
CSX
$98.6B
$3.42M 0.06%
187,968
-3,189
-2% -$54.6K
FDC
335
DELISTED
First Data Corporation
FDC
$3.41M 0.06%
187,546
-26,291
-12% -$440K
STT icon
336
State Street
STT
$50.9B
$3.4M 0.06%
37,891
-57,742
-60% -$4.8M
AMBA icon
337
Ambarella
AMBA
$2.99B
$3.4M 0.06%
69,994
+8,032
+13% +$445K
PX
338
DELISTED
Praxair Inc
PX
$3.38M 0.06%
25,484
+19,737
+343% +$2.53M
STRP
339
DELISTED
Straight Path Communications Inc.
STRP
$3.34M 0.06%
+18,595
New +$2.84M
MAR icon
340
Marriott International
MAR
$98.7B
$3.29M 0.06%
32,787
-113,856
-78% -$11.4M
XLRN
341
DELISTED
Acceleron Pharma
XLRN
$3.28M 0.06%
108,000
-74,000
-41% -$2.14M
SPGI icon
342
S&P Global
SPGI
$126B
$3.27M 0.06%
22,432
-6,912
-24% -$960K
NTAP icon
343
NetApp
NTAP
$32.9B
$3.26M 0.06%
81,314
-71,247
-47% -$2.84M
ESPR
344
DELISTED
Esperion Therapeutics
ESPR
$3.24M 0.06%
+70,000
New +$2.57M
HPQ icon
345
HP
HPQ
$23.5B
$3.24M 0.06%
185,090
-77,419
-29% -$1.42M
TFC icon
346
Truist Financial
TFC
$63.2B
$3.23M 0.06%
71,211
+2,015
+3% +$87.5K
CPRT icon
347
Copart
CPRT
$25.9B
$3.23M 0.06%
406,464
-1,092,832
-73% -$8.37M
GHDX
348
DELISTED
Genomic Health, Inc.
GHDX
$3.22M 0.06%
99,000
+4,000
+4% +$127K
RIGL icon
349
Rigel Pharmaceuticals
RIGL
$680M
$3.22M 0.06%
118,000
+9,500
+9% +$260K
MTB icon
350
M&T Bank
MTB
$36.2B
$3.21M 0.06%
19,846
-2,295
-10% -$362K

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.